Back to Search
DAMANPAUL SONDHI, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1437199015IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
218619(NY)
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
218619(NY)
Education
OTHER
Class of 1992
Research & Publications (16)
AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.
PMID 16052206·Gene Ther·2005
7-preclinical
Feasibility of gene therapy for late neuronal ceroid lipofuscinosis.
PMID 11708986·Arch Neurol·2001
6-review
Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis.
PMID 18639872·Exp Neurol·2008
7-preclinical
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA.
PMID 18473686·Hum Gene Ther·2008
3-trial
Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imaging.
PMID 17698521·AJNR Am J Neuroradiol·2007
8-other
Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.
PMID 17679671·Neurology·2007
4-observational
Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector.
PMID 17180118·Mol Ther·2007
7-preclinical
Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis.
PMID 16452657·J Neurosci·2006
7-preclinical
Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates.
PMID 16390279·Hum Gene Ther·2005
7-preclinical
Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders.
PMID 16149901·Hum Gene Ther·2005
6-review
Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.
PMID 15610613·Hum Gene Ther·2004
3-trial
Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital.
PMID 15302724·Chest·2004
8-other
Castleman's disease and superior vena cava thrombi: a rare presentation and a review of the literature.
PMID 11687872·Mt Sinai J Med·2001
5-case
Wernicke's encephalopathy in a non-alcoholic man: case report and brief review.
PMID 11373696·Mt Sinai J Med·2001
5-case
Microscopic polyangiitis presenting as idiopathic pulmonary fibrosis: is anti-neutrophilic cytoplasmic antibody testing indicated?
PMID 11269798·Am J Med Sci·2001
5-case
Antivector and antitransgene host responses in gene therapy.
PMID 11249767·Curr Opin Mol Ther·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1425 PORTLAND AVENUE
ROCHESTER, NY 14621 - Phone
- (585) 922-4409
Quick Facts
- NPI
- 1437199015
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 34
- Publications
- 16
Are you this provider?
Claim Your Profile